Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details) - USD ($)		3 Months Ended
	Dec. 31, 2025	Mar. 31, 2026
Schedule of Stock Options Vested and Exercisable [Abstract]
Shares, outstanding at Ending balance	924	459,863
Weighted-average exercise price, outstanding at Ending balance	$ 13,475.78	$ 25.73
Weighted-average remaining contractual term (years), outstanding at Ending balance	4 years 4 months 28 days	9 years 11 months 19 days
Aggregate intrinsic value, outstanding at Ending balance
Shares, vested and expected to vest at ending balance		459,863
Weighted-average exercise price, vested and expected to vest at ending balance		$ 25.73
Weighted-average remaining contractual term (years), vested and expected to vest at ending balance		9 years 11 months 19 days
Aggregate intrinsic value, vested and expected to vest at ending balance
Shares, vested and exercisable at ending balance		726
Weighted-average exercise price, vested and exercisable at ending balance		$ 12,893.3
Weighted-average exercise price, vested and exercisable at ending balance		4 years 2 months 23 days
Aggregate intrinsic value, vested and exercisable at ending balance
Shares, Granted		459,031
Weighted- average exercise price, Granted		$ 2
Aggregate intrinsic value, Granted
Shares, Exercised
Weighted-average exercise price, Exercised
Aggregate intrinsic value, Exercised
Shares, Cancelled/forfeited		(92)
Weighted-average exercise price, Cancelled/forfeited		$ 17,075.07
Aggregate intrinsic value, Cancelled/forfeited